Neospora caninum: In vivo and in vitro treatment with artemisone

Veterinary Parasitology

Volumn 187, Issue 1-2, 2012, Pages 99-104

  Mazuz, Monica L ^a   Haynes, Richard ^b   Shkap, Varda ^a   Fish, Leah ^a   Wollkomirsky, Ricardo ^a   Leibovich, Benjamin ^a   Molad, Thea ^a   Savitsky, Igor ^a   Golenser, Jacob ^c,d  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Artemisinin; Artemisone; Gerbil; Neospora caninum; Treatment

Indexed keywords

ARTEMISONE;

ANIMAL CELL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; DRUG TOLERANCE; ENZYME INHIBITION; GERBIL; IN VITRO STUDY; IN VIVO STUDY; NEOSPORA CANINUM; NEOSPOROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROPHYLAXIS; TREATMENT RESPONSE;

ANIMALS; ANTIBODIES, PROTOZOAN; ARTEMISININS; CERCOPITHECUS AETHIOPS; COCCIDIOSIS; COCCIDIOSTATS; DNA, PROTOZOAN; GERBILLINAE; NEOSPORA; POLYMERASE CHAIN REACTION; TIME FACTORS; VERO CELLS;

ANIMALIA; BOS; GERBILLINAE; NEOSPORA; NEOSPORA CANINUM;

EID: 84860685371     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.12.020     Document Type: Article

References (33)

1. Anderson M.L., Andrianarivo A.G., Conrad P.A. Neosporosis in cattle. Anim. Reprod. Sci. 2000, 60-61:417-431.
2. D'Alessandro S., Gelatib M., Basilicoa N., Paratib A.E., Haynesc K., Donatella R.T. Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: implications for embryotoxicity. Toxicon 2007, 241:66-74.
3. Di Giulio G., Lynen G., Morzaria S., Oura C., Bishop R. Live immunization against east coast fever-current status. Trends Parasitol. 2009, 25:85-92.
4. Dubey J.P., Schares G., Ortega-Mora L.M. Epidemiology and control of neosporosis and Neospora caninum. Clin. Microbiol. Rev. 2007, 20:323-367.
5. Dubey J.P., Schares G. Neosporosis in animals-the last five years. Vet. Parasitol. 2011, 180:90-109.
6. Dunay I.R., Chan W.C., Haynes R.K., Sibley L.D. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob. Agents Chemother. 2009, 53:4450-4456.
7. Fioretti D.P., Pasquai P., Diaferia M., Mangilini V., Rosignoli L. Neospora caninum infection and congenital transmission: serological and parasitological study of cows up to the fourth gestation. J. Vet. Med. B 2003, 50:399-404.
8. Fish L., Mazuz L.M., Molad T., Savitsky I., Shkap V. Isolation of Neospora caninum from dairy zero grazing cattle in Israel. Vet. Parasitol. 2007, 149:167-171.
9. Furr M., Kennedy T., MacKay R., Reed S., Andrews F., Bernard B., Bain F., Byars D. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis. Vet. Ther. 2001, 2:215-222.
10. Gottstein B., Razmi G.R., Ammann P., Sage H., Müller N. Toltrazuril treatment to control displacental Neospora caninum transmission in experimentally infected pregnant mice. Parasitology 2005, 130:41-48.
11. Haynes R.K., Fugmann B., Stetter J., Rieckmann K., Heilmann H.D., Chan H.W., Cheung M.K., Lam W.L., Wong H.N., Croft S.L., Vivas L., Rattray L., Stewart L., Peters W., Robinson B.L., Edstein M.D., Kotecka B., Kyle D.E., Beckermann B., Gerisch M., Radtke M., Schmuck G., Steinke W., Wollborn U., Schmeer K., Römer A. Artemisone a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 2006, 45:2082-2088.
12. Haynes R.K. Artemisinins: remarkable antimalarial drugs, current usages and problems, and design of new derivatives and analogues. Workshop on Advanced Design and Development of Potential Drugs against Malaria 2009.
13. Innes E.A., Buxton D., Maley S., Wright S., Marks J., Esteban I., Rae A., Schock A., Wastling J. Neosporosis. Aspects of epidemiology and host immune response. Ann. N. Y. Acad. Sci. 2000, 916:93-101.
14. Kim J.T., Park J.Y., Seo H.S., Oh H.G., Noh J.W., Kim J.H., Kim D.Y., Youn H.J. In vitro antiprotozoal effects of artemisinin on Neospora caninum. Vet. Parasitol. 2002, 103:53-63.
15. Kritzner S., Sager H., Blum J., Krebber R., Greif G., Gottstein B. An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann. Clin. Microbiol. Antimicrob. 2002, 18:1-4.
16. Lindsay D.S., Rippey N.S., Cole R.A., Parson L.C., Dubey J.P., Tidwell R.R., Blagburn B.L. Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. Am. J. Vet. Res. 1994, 55:976-981.
17. López-Pérez I.C., Collantes-Fernández E., Rojo-Montejo S., Navarro-Lozano V., Risco-Castillo V., Pérez-Pérez V., Pereira-Bueno J., Ortega-Mora L.M. Effects of Neospora caninum infection at mid-gestation on placenta in a pregnant mouse model. J. Parasitol. 2010, 96:1017-1020.
18. Mazuz L.M., Fish L., Molad T., Savitsky I., Wolkomirsky R., Leibovitz B., Shkap V. Neospora caninum as causative pathogen of abortion in cattle. Isr. J. Vet. Med. 2011, 66:14-18.
19. Mitchell S.M., Zajac A.M., Davis W.L., Lindsay D.S. Mode of action of ponazuril against Toxoplasma gondii tachyzoites in cell culture. J. Eukaryot. Microbiol. 2003, 50(S):689-690.
20. Nagelschmitz J., Voith B., Wensing G., Roemer A., Fugmann B., Haynes R.K., Kotecka B.M., Rieckmann K.H., Edstein M.D. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 2008, 52:3085-3091.
21. Nontprasert A., Nosten-Bertrand M., Pukrittayakamee S., Vanijanonta S., Angus B.J., White N.J. Assessment of the neurotoxicity of parental artemisinin derivatives in mice. Am. J. Trop. Med. Hyg. 1998, 59:519-522.
22. Ramamoorthy S., Sriranganathan N., Lindsay D.S. Gerbil model of acute neosporosis. Vet. Parasitol. 2005, 127:111-114.
23. Ramharter M., Burkhardt D., Nemeth J., Adegnika A.A., Kremsner P.G. Short report: in vitro activity of artemisone compared with artesunate against Plasmodium falciparum. Am. J. Trop. Med. Hyg. 2006, 75:637-639.
24. Reichel M.P. Neospora caninum infection in Australia and New Zealand. Aust. Vet. J. 2000, 78:258-261.
25. Reichel M.P., Ellis J.T. Control options for Neospora caninum infections in cattle-current state of knowledge. N. Z. Vet. J. 2002, 50:86-92.
26. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T., Spaarman L., de Mast Q., Roeffen W., Snounou G., Rénia L., van der Ven A., Hermsen C.C., Sauerwein R. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
27. Schmuck G., Roehrdanz E., Haynes R.K., Kahl R. Neurotoxic mode of action of artemisinin. Antimicrob. Agents Chemother. 2002, 46:821-827.
28. Schmuck G., Klaus A.M., Krötlinger F., Langewische F.W. Developmental and reproductive toxicity studies on artemisone. Birth Defects Res. B. Dev. Reprod. Toxicol. 2009, 86:131-143.
29. Shkap V., Bin H., Lebovich B., Pipano E. Besnoitia besnoiti: quantitative in vitro studies. Vet. Parasitol. 1991, 39:207-213.
30. Shkap V., Reske A., Pipano E., Fish L., Baszler T. Immunological relationship between Neospora caninum and Besnoitia besnoiti. Vet. Parasitol. 2002, 106:35-43.
31. Strohbusch M., Müller N., Hemphill A., Krebber R., Greif G., Gottstein B. Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice. Parasitol. Res. 2009, 104:1335-1343.
32. Trees A.J., Davison H.C., Innes E.A., Wastling J.M. Towards evaluating the economic impact of bovine neosporosis. Int. J. Parasitol. 1999, 29:1195-1200.
33. Waknine-Grinberg J.H., Hunt N., Bentura-Marciano A., McQuillan J.A., Chan H.W., Chan W.C., Barenholz Y., Haynes R.K., Golenser J. Artemisone effective against murine cerebral malaria. Malar. J. 2010, 9:227.